Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer

Serum Amyloid a Predicts Prognosis and Chemotherapy Efficacy in Patients with Advanced Pancreatic Cancer

Honglu Ding,1,&ast; Qiuxia Yang,2,&ast; Yize Mao,1,&ast; Dailei Qin,1 Zehui Yao,1 Ruiqi Wang,1 Tao Qin,3 Shengping Li1 1Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Can...

Full description

Bibliographic Details
Main Authors:	Ding H, Yang Q, Mao Y, Qin D, Yao Z, Wang R, Qin T, Li S
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-03-01
Series:	Journal of Inflammation Research
Subjects:	advanced pancreatic cancer serum amyloid a chemotherapy prognosis biomarker.
Online Access:	https://www.dovepress.com/serum-amyloid-a-predicts-prognosis-and-chemotherapy-efficacy-in-patien-peer-reviewed-fulltext-article-JIR

Similar Items

Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma
by: Wang Jun-Ye, et al.
Published: (2012-08-01)

Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy
by: Juan Du, et al.
Published: (2022-05-01)

Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis prediction
by: Tianhong Teng, et al.
Published: (2024-03-01)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
by: Cong‐ya Zhou, et al.
Published: (2018-11-01)

Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer
by: Chaobin He, et al.
Published: (2021-02-01)

Systematic Review of Single-Agent vs. Multi-Agent Chemotherapy for Advanced Pancreatic Adenocarcinoma in Elderly vs. Younger Patients
by: Alison Lewis, et al.
Published: (2023-04-01)

Association of serum amyloid A and prognosis in people with diabetes and COVID‐19: A retrospective cohort study
by: Duoduo Qu, et al.
Published: (2024-01-01)

The prognostic role of soluble TGF‐beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy
by: Hyunkyung Park, et al.
Published: (2020-01-01)

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
by: Mariia Kiriukova, et al.
Published: (2020-09-01)

The prognostic value of serum amyloid A in solid tumors: a meta-analysis
by: Hai-yingjie Lin, et al.
Published: (2019-03-01)

Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A
by: Xuguang Lin, et al.
Published: (2021-01-01)

Network Meta-Analysis of Efficacy and Safety of Chemotherapy and Target Therapy in the First-Line Setting of Advanced Pancreatic Cancer
by: Kun-I Lin, et al.
Published: (2019-11-01)

Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresectable Pancreatic Cancer
by: Naoto Iwai, et al.
Published: (2021-07-01)

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial
by: M. S. Walma, et al.
Published: (2021-04-01)

Prognosis of pancreatic cancer with Trousseau syndrome: a systematic review of case reports in Japanese literature
by: Munehiro Wakabayashi, et al.
Published: (2023-12-01)

The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer
by: Argyrios Gyftopoulos, et al.
Published: (2022-05-01)

Advanced pancreatic cancer: the standard of care and new opportunities
by: Amrallah A. Mohammad
Published: (2018-09-01)

Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients
by: Wang S, et al.
Published: (2024-04-01)

Serum amyloid a protein as a potential biomarker in predicting acute onset and association with in-hospital death in acute aortic dissection
by: Yuchen He, et al.
Published: (2019-12-01)

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
by: Dominik Andreas Barth, et al.
Published: (2020-08-01)

Serum cholesterol level as a predictive biomarker for prognosis of Neuroblastoma
by: Jie Min, et al.
Published: (2024-03-01)

Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
by: Changhoon Yoo, et al.
Published: (2019-02-01)

Consolidative Chemoradiotherapy After Induced Chemotherapy Is an Optimal Regimen for Locally Advanced Pancreatic Cancer
by: Lili Wu, et al.
Published: (2020-01-01)

Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review
by: Karolina Wilczyńska, et al.
Published: (2020-10-01)

Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma
by: Bo Li, et al.
Published: (2021-05-01)

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer
by: Sung Jun Ma, et al.
Published: (2018-11-01)

First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis
by: Zhang S, et al.
Published: (2018-11-01)

Serum amyloid A4 is a procoagulant apolipoprotein that it is elevated in venous thrombosis patients
by: José A. Fernández, et al.
Published: (2020-02-01)

Prognostic Value for Perioperative Serum Total Cholesterol Level on Postoperative Long-Term Prognosis of Pancreatic Cancer: A Retrospective Clinical Study
by: Han-Xuan Wang, et al.
Published: (2023-04-01)

Regional hyperthermia combined with chemotherapy in advanced gastric cancer
by: Fang Hongming, et al.
Published: (2019-02-01)

Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays
by: Jin Song, et al.
Published: (2021-12-01)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
by: Sumit Sahni, et al.
Published: (2023-09-01)

The Pre-Ablation Circulating Tumor-Associated Inflammatory Index Predicts the Prognosis of Patients with Liver Metastasis from Pancreatic Cancer
by: Li Y, et al.
Published: (2022-10-01)

Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy
by: Sidsel C. Lindgaard, et al.
Published: (2022-07-01)

Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis
by: Chaobin He, et al.
Published: (2019-04-01)

Efficacy and Safety of Chemotherapy in Elderly Patients with Unresectable Pancreatic Cancer
by: Byung Soo Kwan, et al.
Published: (2023-05-01)

Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo
by: Raya Al-Shawi, et al.
Published: (2016-01-01)

Evaluation of serum miR‐216a and miR‐375 as biomarkers in dogs with acute pancreatitis
by: Dohee Lee, et al.
Published: (2023-01-01)

Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy
by: Yan Lin, et al.
Published: (2022-06-01)

Individualized Prediction of Survival Benefits of Pancreatectomy Plus Chemotherapy in Patients With Simultaneous Metastatic Pancreatic Cancer
by: Duorui Nie, et al.
Published: (2021-09-01)